ROYAL COLLEGE OF PODIATRY

>

>

Independent prescribing remains limited among podiatrists, new report finds

Independent prescribing remains limited among podiatrists, new report finds

A report from the Nuffield Trust finds that 7% of UK podiatrists are independent prescribers, rising to 12% in Scotland, highlighting the slow uptake of the non-medical prescribing qualification since its approval in 2013

medication on a yellow background

What’s happened 

Across allied health professions, uptake is broadly similar: 4% of physiotherapists and 5% of therapeutic radiographers are independent prescribers, while paramedics, like podiatrists, stand at 7%. 

However, the gap is more pronounced when compared with other parts of the workforce. Pharmacists have the highest proportion of prescribers, with around 33% qualified, while nurses make up the largest group overall, accounting for 69% of all independent prescribers. 

There are now nearly 100,000 independent prescribers across the UK, representing almost a quarter of the prescribing workforce. The report positions them as central to plans to move care out of hospitals and into neighbourhood settings. 

Why this matters to members 

Independent prescribing is widely seen as a way to improve patient care and make fuller use of clinical skills. For podiatry, the current level of uptake suggests there is room to expand its use, particularly as care moves closer to home. 

The report also highlights wider systemic challenges, including limited access to training and supervision, gaps in workforce planning and the risk that qualified prescribers are not always able to use their skills in practice. 

Jim Pickard, Chair of the Medicines and Medical Devices Committee at the Royal College of Podiatry, said the report reflects both progress and ongoing challenges. 

“The report reflects what many podiatrists already see in practice. Independent prescribing is growing, but we need to keep building momentum, both by increasing the number of prescribers and by supporting experienced clinicians to train the next generation. We continue to work with the Medicines and Healthcare products Regulatory Agency (MHRA) and the Commission on Safety of Medicines (CSM) on the expansion of the list of controlled drugs available to podiatrists, alongside this work.” 

He also highlighted the importance of better data on prescribing practice. 

“We also need a clearer picture of who is accessing prescription-only medicines through exemptions and who is prescribing as an independent prescriber and in which areas of practice. That information is essential for safe practice, good governance and planning the workforce effectively.” 

The Royal College of Podiatry contributed to the report through participation with the research team. Planned improvements to its membership database, as part of a wide-ranging digital transformation, along with a provision of relevant CPD are expected to strengthen how prescribing data is captured. 

What happens next 

The report is likely to inform future workforce planning, particularly as independent prescribing is expected to grow across professions and play a larger role in neighbourhood care models. 

For podiatry, this is likely to mean a continued focus on increasing training capacity, improving access to supervision and ensuring prescribing skills are used effectively in practice.

References and links

Nuffield Trust: Independent prescribing in the UK: Workforce ambitions and implementation challenges

Featured Posts

Related Post

Jul 30, 2026

Post by

The UK’s Chief Medical Officers have updated their physical activity guideline infographics. Professionals can use them to promote clear and consistent messages about moving more.

Jul 28, 2026

Post by

Diabetic foot ulcers are one of the most familiar presentations in podiatric practice. Occasionally, though, an ulcer is not all it seems. Michelle Reynolds explains the subtle signs that could indicate melanoma.

Jul 20, 2026

Post by

Healthcare professionals are being advised that batches of ChloraPrep 2% applicators with an expiry date up to and including May 2029 are being recalled due to a potential sterility issue affecting the packaging process.

Jul 14, 2026

Post by

Rafael Nadal was one of the most successful tennis players of his generation. At age 19, however, his career was seriously threatened by chronic midfoot pain. He chose to play on, adopting a highly unconventional – and potentially controversial – approach to pain management.

Jul 9, 2026

Post by

The Royal College of Podiatry has issued a position statement on the use of injectable hyaluronic acid-based dermal hydrogels in the foot. While these treatments are attracting growing interest, the College says that patient safety, prescribing compliance and strong clinical governance must remain the priority.

Jul 1, 2026

Post by

Healthcare professionals are being advised that certain packs of Flucloxacillin Capsules BP 500mg contain the wrong patient information leaflet (PIL).

Jul 30, 2026

Post by

The UK’s Chief Medical Officers have updated their physical activity guideline infographics. Professionals can use them to promote clear and consistent messages about moving more.

Jul 28, 2026

Post by

Diabetic foot ulcers are one of the most familiar presentations in podiatric practice. Occasionally, though, an ulcer is not all it seems. Michelle Reynolds explains the subtle signs that could indicate melanoma.

Jul 20, 2026

Post by

Healthcare professionals are being advised that batches of ChloraPrep 2% applicators with an expiry date up to and including May 2029 are being recalled due to a potential sterility issue affecting the packaging process.

Jul 14, 2026

Post by

Rafael Nadal was one of the most successful tennis players of his generation. At age 19, however, his career was seriously threatened by chronic midfoot pain. He chose to play on, adopting a highly unconventional – and potentially controversial – approach to pain management.

RCPod Annual Conference

Podiatry 2026

Podiatry 2026

Podiatry 2026

Two events, three days of high-impact CPD — our reimagined annual conference and exhibition, plus the RCPod Learning Academy Immersive Day.

Two events, three days of high-impact CPD — our reimagined annual conference and exhibition, plus the RCPod Learning Academy Immersive Day.

26–28 November

ICC Birmingham

Your place

26–28

Nov 2026

ICC Birmingham

Conference & Exhibition + Immersive Day

Early bird closes 31 Aug

Book your place

Member, concession & non-member rates available.